Emory Vaccine Center
Mary Galinski Received Professor Emerita Appointment
Mary Galinski, PhD, is finalizing her plans for retirement later this year. She will end a 35-year full-time academic career in malaria research, with numerous local and global collaborations. Dr. Galinski will look forward to following the careers of her students and fellows, especially those who have become established academic scientists with clinically relevant research programs involving malaria in humans, nonhuman primates, and mosquitoes. She built a one-of-a-kind program at Emory and this will live on through her trainees. Dr. Galinski will remain engaged with the Emory community as a Professor Emerita, while pursuing other interests.
The Center for AIDS Research at Emory University (Emory CFAR) received a five-year award from the National Institutes of Health (NIH) to further its work aimed at ending the HIV epidemic through the highest-caliber translational research.
First established in 1998, the Emory CFAR is part of a national network of 19 NIH-funded centers that provide administrative support, scientific services and programming to promote HIV research. The national CFAR program is particularly focused on supporting early career faculty in their journey to independent HIV investigators by offering pilot funding, mentorship and professional development. CFARs compete every five years to renew their funding and must demonstrate continued research growth, strong institutional support, active recruitment and mentoring of HIV investigators, and provide evidence of an impact in the local HIV/AIDS response.
Emory Vaccine Center Appointments:
- Ann Chahroudi, MD, PhD, Associate Professor, Department of Pediatrics, Infectious Disease
- David Gordon, PhD, Assistant Professor, Department of Pathology and Laboratory Medicine.
- Mohamed Abdel-Hakeem, PhD, Assistant Professor, Department of Pathology and Laboratory Medicine.
- Tomas Garzon-Muvdi, MD, Assistant Professor, Department of Neurosurgery.
- Eric Ortlund, PhD, Professor, Department of Biochemistry.
- Fikri Avci, PhD, Associate Professor, Department of Biochemistry.
Biological Discovery through Chemical Innovation
Applications are now open for Year 4 of the Biological Discovery through Chemical Innovation (BDCI) Accelerator Grants! These awards are aimed at providing seed funding for new projects and recent collaborations that both enhance interdisciplinary research and drive innovation throughout the Emory scientific community. We will fund up to five Accelerator Grants at $40,000 (direct costs) to interdisciplinary teams of Emory researchers. Preference will be given to projects and collaborations that were formed out of BDCI programming and are in alignment with the goals of the BDCI, which are to:
- Establish a broad and diverse network of Emory researchers at the key intersection of biology, chemistry, and human health
- Support the translation of biological insights to chemical tools and the utilization of these tools to promote understanding of disease mechanisms
- Accelerate the development of the next generation of chemical tools, safe & effective drugs, and diagnostic agents
Visit the BDCI website to learn more about eligibility, key dates, and details on the application requirements. If you have any questions, please contact Callie Wigington, Managing Director of the BDCI.